Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection.
10.3904/kjim.2015.30.4.550
- Author:
Na Ri LEE
1
;
Ji Won JANG
;
Hee Sun KIM
;
Ho Young YHIM
Author Information
1. Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea. yhimhy@jbnu.ac.kr
- Publication Type:Case Reports ; Letter
- Keywords:
Lung diseases, interstitial;
Imatinib mesylate;
Tuberculosis
- MeSH:
Adult;
Antineoplastic Agents/*adverse effects;
Antitubercular Agents/therapeutic use;
Biopsy;
Female;
Gastrointestinal Stromal Tumors/*drug therapy/pathology/surgery;
Humans;
Imatinib Mesylate/*adverse effects;
Lung Diseases, Interstitial/*chemically induced/diagnosis;
Mycobacterium tuberculosis/*isolation & purification;
Protein Kinase Inhibitors/*adverse effects;
Rectal Neoplasms/*drug therapy/pathology/surgery;
Tomography, X-Ray Computed;
Tuberculosis, Pulmonary/diagnosis/drug therapy/*microbiology
- From:The Korean Journal of Internal Medicine
2015;30(4):550-553
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
